I n order to give the best care to patients and families, paediatricians need to integrate the highest quality scientific evidence with clinical expertise and the opinions of the family. 1 Archimedes seeks to assist practising clinicians by providing ''evidence based'' answers to common questions which are not at the forefront of research but are at the core of practice. In doing this, we are adapting a format which has been successfully developed by Kevin Macaway-Jones and the group at the Emergency Medicine Journal-''BestBets''.
A word of warning. The topic summaries are not systematic reviews, through they are as exhaustive as a practising clinician can produce. They make no attempt to statistically aggregate the data, nor search the grey, unpublished literature. What Archimedes offers are practical, best evidence based answers to practical, clinical questions.
The format of Archimedes may be familiar. A description of the clinical setting is followed by a structured clinical question. (These aid in focusing the mind, assisting searching, 2 and gaining answers. 3 ) A brief report of the search used followsthis has been performed in a hierarchical way, to search for the best quality evidence to answer the question. 4 A table provides a summary of the evidence and key points of the critical appraisal. For further information on critical appraisal, and the measures of effect (such as number needed to treat, NNT) books by Sackett 5 and Moyer 6 may help. To pull the information together, a commentary is provided. But to make it all much more accessible, a box provides the clinical bottom lines.
The electronic edition of this journal contains extra information to each of the published Archimedes topics. The papers summarised in tables are linked, by an interactive table, to more detailed appraisals of the studies. Updates to previously published topics will be linked to the original article when they are available.
Electronic-only topics that have been published on the BestBets site (www.bestbets.org) and may be of interest to paediatricians include:
N Atropine: re-evaluating its use during paediatric RSI N Absorbable sutures in paediatric lacerations Readers wishing to submit their own questions-with best evidence answers-are encouraged to review those already proposed at www.bestbets.org. If your question still hasn't been answered, feel free to submit your summary according to the Instructions for Authors at www.archdischild.com. Three topics are covered in this issue of the journal. 
Randomisation
Randomisation is used within the context of therapeutic studies to try to reduce bias. It does this by using chance to spread, hopefully evenly, important prognostic factors across the groups within the study. Randomisation can be performed in a number of ways; each variation can be used in different trial situations. To make life easier, for this article we'll assume there are just two arms, but the principles apply to studies with greater numbers of options too. Simple randomisation is as straightforward as tossing a coin for each individual entered. In small studies, doing this may run the risk of having an uneven number of participants in the trial arms, making interpretation more difficult. The simplest variation on this is to predetermine the number of individuals in the study, and (metaphorically) put the appropriate number of ''A''s and ''B''s in a bag and withdraw the letters. This gives an even spread of numbers across the study arms-but is impossible to achieve for very large studies.
Block randomisation is where a block of participants (typically 6-12 in size) is randomised into an even split between ''A''s and ''B''s. This lets ''time'' be balanced between the arms too-for example, winter versus spring admissions-and balances the workload between the armsif the treatments are not drug therapies but physiotherapy, surgery, or a multidisciplinary team intervention. It also allows a study to stop with an even spread between the arms. However, if the blocks are of the same size it may be possible for investigators to start to guess what's coming next, upsetting the allocation concealment and jeopardising the trial. 1 One way around this is taking blocks of 6, 8, and 10 participants and randomising the order of these too.
Stratified randomisation is a method where the investigator doesn't leave the distribution of known or presumed prognostic variables entirely to chance; instead each major variable (for example, age, tumour stage, biological marker) is treated almost as a separate mini-trial, and participants within these strata are randomised independent of the other strata. (As a rule of thumb, you need at least 10 participants in each arm to make this valuable.) A similar type of process is used in minimisation allocation, which achieves similar results by a slightly different method.
Finally, cluster randomisation should be used when the unit randomised is not an individual child or family, but institution or group. For example, a trial of providing mosquito netting to prevent malaria may randomise villages, a study of a new computerised decision support system may randomise family practices. A 3 year old boy is admitted to a paediatric intensive care unit with a history of fever, non-blanching petechial rash, decreased conscious level, and grunting; capillary refill is poor. After screening for sepsis, antibiotics are started. He is intubated, receives fluid resuscitation (total of 100 ml/ kg), and a central catheter is placed, showing a central venous pressure of 12 mm Hg. Despite dopamine infusion the attending physician is unable to stabilise his blood pressure, and he requires noradrenaline infusion to achieve and maintain his haemodynamic state. Search outcome: 68 hits (3; 52; 13; each search respectively), of which 6 (0; 3; 3) studies were directly relevant to the question. See tables 1 and 2.
Structured clinical question

Commentary
The use of steroids in septic shock has been discussed for decades. The use of high dose steroids (30 mg/kg of methylprednisolone or equivalent) for a short period has been proven not to improve outcome. 1 However, the use of low doses (200-300 mg of hydrocortisone in adults; around 2-5 mg/kg/day in children) for longer periods (replacement therapy) has shown very promising results in adults. [2] [3] [4] Table 1 summarises the main randomised controlled trials testing the use of steroids in low dose for septic shock. Although there is a discrepancy in the populations (and on the criteria for adrenal insufficiency), replacement therapy with steroids showed either significant reduction in the duration of inotrope requirement and 28 day mortality, or a tendency towards improvement. Although no studies have evaluated the use of steroids in paediatric septic shock, expert opinion (for example, the Society of Critical Care Medicine clinical practice parameters 8 ) recommends the use of hydrocortisone in children with septic shock requiring catecholamines for blood pressure support and adrenal insufficiency, as evidenced by total cortisol lower than 18 mg/dl.
Meningococcal septic shock presents with an early, massive inflammatory response. Although absolute adrenal failure due to adrenal haemorrhage is rare, partial adrenal insufficiency has been described in these children even in the absence of adrenal haemorrhage. [5] [6] [7] Table 2 summarises the main studies that have evaluated adrenal function in children with meningococcal disease. The incidence of adrenal insufficiency varied from 10.3% to 16.9% in children with shock. Of note, children with very severe disease had lower cortisol levels than children with a moderate presentation.
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Moreover, after a low dose Synacthen test, cortisol levels did not increase as much in the more severely affected children as they did in children with mild disease. 5 These data support the hypothesis that children with meningococcal shock, particularly the more severely affected, can present with reduced adrenal response.
In summary, children with meningococcal shock have increased incidence of abnormal adrenal response, and extrapolation of data from adult septic shock and expert opinion supports the use of hydrocortisone replacement therapy in children with meningococcal shock dependent on catecholamines. Commentary Henoch-Schonlein purpura is the most common vasculitic disease in childhood, most commonly affecting the skin, joints, gastrointestinal tract, and kidneys. Gastrointestinal involvement is said to occur in approximately 80% of patients, ranging from mild symptoms such as abdominal pain, nausea, and vomiting, to more severe manifestations such as gastrointestinal bleeding and intussusception. Some textbooks suggest that the abdominal pain of HSP may respond to steroids, with some suggesting that there is a benefit in their use and describing a regimen. No randomised controlled trials have ever been carried out to assess this problem and there have been no systematic reviews to date looking at the available data. The studies that are available include retrospective studies and case series. These studies show that children with HSP who are treated with steroids experience a quicker resolution of their pain than those not treated with steroids. This is seen within 24 hours of commencing treatment in the studies by Rosenblum and Reinehr et al.
Should children with
Although the groups were similar for some characteristics, randomisation and blinding was not carried out-thus there is little to ensure that patients were equal in terms of factors such as severity of illness.
While steroids have been described in these studies as having a beneficial effect on abdominal pain, they are also known to have adverse effects, some of which have been noted in these studies-for instance, the masking of associated intra-abdominal pathology such as intussusceptions and bowel perforation.
A randomised controlled trial seems the natural next step in order to answer this question. If we assume that a trial looking at the effect of steroids for severe abdominal pain will have a power of 80% at a 5% significance level and assume 15% complete resolution of pain at 24 hours in placebo treated children and 25% resolution of pain in children treated with steroids, we would need 247 children in each group to complete this trial. Larger effects would be easier to detect, but even assuming a doubling of pain relief using steroids we would still need over 100 subjects per arm. A large district general hospital serving a population of 100 000 children would only see 18 children a year with HSP, of whom only six might have severe abdominal pain.
It is clear that this has affected why a prospective trial has not been carried out to date, as to do so would involve the detection of a small treatment effect, of an uncommon symptom (severe abdominal pain) in an uncommon condition. Ideally a large multicentre trial is needed, but an alternative approach may be a well designed large cohort study; one possibility may be to conduct it under the aegis of a body such as the British Paediatric Surveillance Unit.
Do cuffed endotracheal tubes increase the risk of airway mucosal injury and postextubation stridor in children? experience in ventilating children with this condition is that they often develop acute respiratory distress syndrome, and require high pressures to maintain adequate oxygenation and ventilation. At these high pressures significant leaks occur around the endotracheal tube, impairing effective ventilation, and on occasion it is necessary to change to an endotracheal tube of greater diameter. Re-intubation under such circumstances carries a greater risk of hypoxia because of the inevitable loss of positive airway pressure during the procedure. You think it would be wise to insert a cuffed endotracheal tube, in which the cuff could be inflated if leak becomes a problem. It has been traditionally taught that only uncuffed endotracheal tubes should be used for intubation in children under the age of 8 years to decrease the risk of airway mucosal injury and postextubation stridor. You wonder if there is any evidence to the above statement. Cochrane-endotracheal tube. Pubmed-cuffed endotracheal tube AND children. Limits-RCT, English and child ,18 years.
Outcome
Cochrane central register of controlled trials-1.
Pubmed-1 RCT (same study as in Cochrane register). Limits excluding RCT-15 hits, of which 3 were relevant (1 review and 2 case control studies).
See table 4.
Commentary
Traditionally it has been taught that only uncuffed endotracheal tubes (ETT) should be used for children under the age of 8 years. 4 5 Concerns regarding the use of cuffed ETTs originate from studies in adults 6 7 and animals 8 which indicate that cuffed tubes impair tracheal mucosal blood flow and are associated with higher incidence of postextubation laryngeal oedema and tracheal stenosis. The pathological process of stenosis is thought to begin with tracheal tube pressure on the laryngotracheal mucosa, especially when the tube is too large or when the cuff is too inflated, causing mechanical oedema and ischaemic necrosis, followed by organisation into fibrotic tissue. However these data described the use of high-pressure, low-volume cuffed ETTs. Studies 9 have documented a causal relation between the duration of intubation and the occurrence of laryngeal mucosal inflammation for cuffed and uncuffed ETTs. Subsequent studies 1-3 using the modern high-volume, low-pressure cuffs have not shown any increase in the incidence of post-extubation stridor. In fact cuffed ETTs have been shown to decrease the number of laryngoscopies, 1 reduce the risk of aspiration, and improve end-tidal CO 2 monitoring. 10 None of the studies were designed to compare incidence of subglottic stenosis between children intubated with cuffed or uncuffed endotracheal tubes. A cases series from France of five children with subglottic stenosis found that only one had immediate post-extubation stridor, with the others developing symptoms of dyspnoea 4-13 days after extubation. 11 For this reason, it cannot be assumed that the absence of immediate This case is based on experience from several cases. Details have been altered to ensure patient anonymity
